Embedded Files
The name Avenir comes from the French word for "the future" - a nod to the French heritage of our founder and, more importantly, to the purpose that drives our work.
Every MedTech start-up begins with a vision to improve healthcare and change patients' lives. Avenir Health Strategies exists to help turn that vision into reality by guiding companies through the complex journey from innovation to commercial success.
The name is a reminder that every strategic decision made today helps shape the future of healthcare.
Experience that matters
Experience that matters
Avenir Health Strategies is built on executive experience gained inside some of Australia's most innovative MedTech companies.
We have helped organisations:
✓ Lead first-in-human clinical programmes
✓ Achieve ISO 13485 and MDSAP certification
✓ Develop global regulatory strategies
✓ Scale organisations from early-stage start-ups to commercial readiness
✓ Support fundraising and investor engagement
✓ Establish international manufacturing and supplier networks
✓ Commercialise AI, Software as Medical Device and Biosensor technologies
Founded by Celine Royet, PharmD, RAC, the company brings more than 20 years of international executive experience across regulatory affairs, clinical strategy, operational scale-up and commercial readiness. Throughout her career, Celine has supported venture-backed start-ups, ASX-listed companies and multinational healthcare organisations in bringing innovative medical technologies to market across Australia, Europe and the United States.
Having served on executive leadership teams responsible for company growth, fundraising support, regulatory strategy, clinical readiness and operational transformation, we understand the strategic decisions that shape successful MedTech businesses.
Avenir Health Strategies exists because early-stage MedTech companies deserve access to executive-level commercialisation expertise - long before they can justify hiring a full executive team
Page updated
Google Sites
Report abuse